SHL at the 2016 Prefillied Syringes Seminar Tokyo
pharmafile | April 28, 2016 | News story | Manufacturing and Production |
SHL is glad to announce that it is going to participate in the Prefilled Syringe Seminar 2016 Tokyo, organized by PDA Japan Chapter. The seminar will take place at Sola City Conference Center on 17-18 of May 2016.
This year SHL is going to speak about the requirements on prefillable containers for the perfect fit into devices. The issue is important and widely discussed in the pharmaceutical and manufacturing industries and SHL is proud to make its contribution to the debate.
In addition to being a speaker at the seminar, SHL will also participate in the exhibition accompanying it. The spotlight will be on our two latest products – Molly® 2.25 and Molly® C.
Molly® 2.25 is our large-volume auto injector based on the Molly® preconfigured program. Mike Weng, Executive Director of Business Development for Asia comments: “We are very proud to bring Molly 2.25 to Japan. As our first large-volume auto injector, Molly® 2.25 creates the long-needed bridge between larger volume primary containers and drug delivery.”
SHL’s most recent and most innovative product – Molly® C – is a connected auto injector that transmits injection data to the user’s mobile device. It was developed as a part of our connectivity-dedicated program Alubena® to showcase the benefits and prospects of connected products.
Molly® 2.25, Molly® C and other SHL products will be available for demonstration at the exhibition. The exhibition will take place parallel to the seminar in the East Room of Sola City Conference Center on the 2nd floor.
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices such as auto injectors and pen injectors. We have over 3,000 staff globally, with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of several distinct group companies:
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
Develops and manufactures equipment solutions for home, hospital and long term care use
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
Provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries
For additional information visit www.shl-group.com or contact us at email@example.com